The Microfluidics team was excited to participate as joint presenters on June 17, 2021, with our Turkish colleagues from Anamed & Analitik Group to discuss: Efficient Production of Liposomes, Lipid Nanoparticles and similar Vesicles with Microfluidizer® Technology.
Overview of Liposomes
Small molecules, nucleic acids and proteins can be packaged in lipid-based nanoparticles and used for both drug and vaccine transmission. As one of the most successful delivery systems for clinical use, liposomes offer better efficacy and less toxicity with a targeted delivery compared to other delivery systems. However, replicating research and development results into production of lipid-based nanoparticles (liposomes, lipid nanoparticles and solid lipid nanoparticles) must address many challenges guaranteeing a consistent, repeatable product
Topics included in this discussion are:
- Liposomes - an overview of their advantages and benefits
- Liposomes for vaccine and drug delivery
- An in-depth examination of liposome formulation and preparation
- Examination of the solvent-free manufacturing process
- Demonstration of Microfluidizer® technology from priming to processing
- Case studies of aqueous soluble small molecules, lipid-soluble drugs
- A scalable method for producing liposomes with cGMP capability.
Presenters:
- Nejla Kilic Arslaner, – Anamed & Analitik Group
- Dr. Yang Su, - New Technology and Applications Manager at Microfluidics
- Chris Jaquin, Applications Engineer at Microfluidics
For more information about the webinar subject matter, please Contact our team.
Learn more about Anamed & Analitik
To learn more about Microfluidics comprehensive selection of superior Microfluidizer® processors.
Posted by
Cathy Silva